# Major Recall Alert: Cefazolin for Injection, USP, 1 gm Vial Recalled Due to Mislabeled Vials
A new recall alert has been issued by Sandoz Inc., raising concerns across the medical community and among patients. The issue stems from **vials incorrectly labeled as Penicillin G Potassium for Injection that actually contain Cefazolin for Injection, USP, 1 gm vials**. This mislabeling poses significant safety risks due to potential medication errors, especially for individuals with allergies or sensitivities.
Healthcare professionals and patients should take immediate precautions to ensure the affected product is identified and not administered. Keep reading for full details on this important recall and steps you can take to stay safe.
## Why This Recall Is Important
The mislabeling of antibiotics such as Cefazolin for Injection as Penicillin G Potassium can lead to serious health risks, including:
- **Medication errors:** A patient requiring penicillin for bacterial treatment may receive cefazolin instead, potentially leading to ineffective treatment.
- **Severe allergic reactions:** Individuals allergic to cefazolin or other components of the drug could experience life-threatening conditions such as anaphylaxis.
- **Enhanced risk in sensitive patients:** This issue is particularly dangerous for those with penicillin allergies who may unknowingly be exposed to cefazolin, introducing unnecessary medical complications.
The recall was expanded on **June 27, 2025**, to include **one additional lot** of the affected product. The error highlights the critical importance of labeling accuracy in medical products and emphasizes the risks associated with using mislabeled medications.
## Details of the Recall
According to the **official FDA notice**, this voluntary recall by Sandoz Inc. includes:
- **Product involved:** Cefazolin for Injection, USP, 1 gm vials
- **Issue:** Vials were incorrectly labeled as Penicillin G Potassium for Injection
- **Expansion date:** June 27, 2025
- **Safety concern:** Risk of medication errors and potential allergic reactions or ineffective treatment
For a complete reference, read the **FDA recall announcement here**: [FDA Recall Page](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/update-sandoz-inc-issues-voluntary-nationwide-recall-expansion-one-additional-lot-cefazolin).
## What You Should Do
Sandoz Inc. advises immediate action for those in possession of mislabeled Cefazolin for Injection vials, including the following steps:
1. **Verify your inventory:** Healthcare facilities and pharmacies should check all vials labeled as Penicillin G Potassium for Injection to confirm their contents.
2. **Quarantine affected lots:** If mislabeled vials are identified, isolate them immediately to prevent accidental use.
3. **Contact the supplier:** Reach out to Sandoz or the distributor to inquire about returns, replacements, or further instructions.
4. **Consult healthcare professionals:** Patients who believe they have received the mislabeled product should speak with their healthcare provider to determine any potential health implications.
Consumers or healthcare providers with questions regarding this recall can contact Sandoz directly for support.
## Stay Safe – Get Instant Recall Alerts
Medication safety is a serious concern, and staying updated on recalls can protect your health or even save lives. Don’t wait—ensure you are always informed about critical updates by subscribing to real-time alerts.
Take control of your health and download our free app today to get **instant medication recall notifications, product safety alerts**, and other essential healthcare updates tailored just for you.
Stay informed. Stay safe.
---
For more information about this recall and safety protocols, visit the official **[FDA website](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/update-sandoz-inc-issues-voluntary-nationwide-recall-expansion-one-additional-lot-cefazolin)**.